Substantiation of the ethiopathogenic choice of substitution therapy medications for the dry eye syndrome.
DOI:
https://doi.org/10.26641/2307-0404.2020.2.206372Ключові слова:
dry eye syndrome, substitution therapy medications, ethiopathogenic treatmentАнотація
The purpose of the study is to substantiate the personalized selection of substitution therapy medications with the consideration of the pathogenesis of dry eye syndrome development in each patient. In order to achieve the set goal, we conducted a content-analysis of the information fromnomenclature on active ingredient as well as on the mechanisms ofaction of substitution therapy medications provided in the prescribing information and labeling of the medications. After that, we performed a pathogenetic ranging of substitution therapy medications depending on the way they influence a certain aspect of disorder of the tear film renewal process in dry eye syndrome. The information received in the course of the conducted research makes it possible for an ophthalmologist – basing on information on the disorder in the quantitative and qualitative correlation between the tear film layers received with the help of modern diagnostic tools to prescribe targeted dry eye syndrome treatment taking into account the necessary point of application of the substitution therapy medications, considering their composition and action mechanism of the active ingredients which they contain.Посилання
[State Register of Medicines of Ukraine]. [Internet]; 2019. Ukrainian. Available from: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument
[State Register of Medical Equipment and Medical Devices]. [Internet]; 2019. Ukrainian. Available from: http://dls.gov.ua/wp-content/uploads/2018/07/%D0%A0%D0%B5%D0%B5%D0%B5%D1%81%D1%82%D1%80.pdf
[Medicines Reference Compendium]. [Internet]; 2019. Ukr. Available from: https://compendium.com.ua/uk
[Dry eye syndrome. Evidence-based clinical guidance]. [Internet]; 2019. Ukrainian. Available from: https://www.dec.gov.ua/mtd/home/
Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul. Surf. 2017;15:276-83. doi: https://doi.org/10.1016/j.jtos.2017.05.008
Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II diagnostic methodology report. Ocul. Surf. 2017;15:539-74. doi: https://doi.org/10.1016/j.jtos.2017.05.001
Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul. Surf. 2017;15:334-65. doi: https://doi.org/10.1016/j.jtos.2017.05.003
Jones L, Downie LE, Korb D, Benitez-del-Castillo JM, Dana R, Deng SX, et al. TFOS DEWS II management and therapy report. Ocul. Surf. 2017;15:575-628. doi: https://doi.org/10.1016/j.jtos.2017.05.006
Bron AJ, dePaiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocul. Surf. 2017;15:438-510. doi: https://doi.org/10.1016/j.jtos.2017.05.011
Willcox MDP, Argüeso P, Georgiev G, Holopainen J, Laurie G, Millar T, et al. TFOS DEWS II tear film report. Ocul. Surf. 2017;15:366-403. doi: https://doi.org/10.1016/j.jtos.2017.03.006
##submission.downloads##
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2020 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.